Search research articles
Contact Us
Filters
Showing results (11-20 of 111) with videos related to
Page
of 12
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 8, 2024
How the prospect of a clinical trial impacts decision-making for predictive genetic testing in ALS
Myriam Fontaine, Kayla Horowitz, Nancy Anoja, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 25, 2026
Opportunities and challenges related to participant stratification and cohort enrichment in ALS clinical trials
Sabrina Yusuf, Matti D Allen, HyungMo Kang, et al.
AJNR. American Journal of Neuroradiology
|
March 15, 2003
Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy
Sanjay Kalra, Neil R Cashman, Zografos Caramanos, et al.
Magnetic Resonance Imaging
|
November 7, 2016
Hair product artifact in magnetic resonance imaging
Sneha Chenji, Alan H Wilman, Dennell Mah, et al.
Dysphagia
|
May 5, 2018
A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD)
Ashley A Waito, Catriona M Steele, Melanie Peladeau-Pigeon, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 20, 2023
Harmonized standard operating procedures for administering the ALS functional rating scale-revised
Jeremy M Shefner, Tommy Bunte, Gale Kittle, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
April 8, 2015
Feasibility of Lung Volume Recruitment in Early Neuromuscular Weakness: A Comparison Between Amyotrophic Lateral Sclerosis, Myotonic Dystrophy, and Postpolio Syndrome
Marta Kaminska, Franceen Browman, Daria A Trojan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 7, 2026
Cell free miRNAs are pharmacodynamic biomarkers for enhanced Dicer activity by Enoxacin in human patients with Amyotrophic lateral sclerosis
Iddo Magen, Hannah Marlene Kaneb, Maria Masnata, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 30, 2026
The World Federation of Neurology Specialty Group in ALS/MND: toward strategic partnership and new frontiers
Matthew C Kiernan, Angela Genge, Julian Grosskreutz, et al.
Drugs in R&D
|
June 20, 2022
Analysis of the US Safety Data for Edaravone (Radicava<sup>®</sup>) From the Third Year After Launch
Angela Genge, Benjamin Rix Brooks, Björn Oskarsson, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 111) with videos related to
Sort By:
Page
of 12
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 8, 2024
How the prospect of a clinical trial impacts decision-making for predictive genetic testing in ALS
Myriam Fontaine, Kayla Horowitz, Nancy Anoja, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 25, 2026
Opportunities and challenges related to participant stratification and cohort enrichment in ALS clinical trials
Sabrina Yusuf, Matti D Allen, HyungMo Kang, et al.
AJNR. American Journal of Neuroradiology
|
March 15, 2003
Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy
Sanjay Kalra, Neil R Cashman, Zografos Caramanos, et al.
Magnetic Resonance Imaging
|
November 7, 2016
Hair product artifact in magnetic resonance imaging
Sneha Chenji, Alan H Wilman, Dennell Mah, et al.
Dysphagia
|
May 5, 2018
A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD)
Ashley A Waito, Catriona M Steele, Melanie Peladeau-Pigeon, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 20, 2023
Harmonized standard operating procedures for administering the ALS functional rating scale-revised
Jeremy M Shefner, Tommy Bunte, Gale Kittle, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
April 8, 2015
Feasibility of Lung Volume Recruitment in Early Neuromuscular Weakness: A Comparison Between Amyotrophic Lateral Sclerosis, Myotonic Dystrophy, and Postpolio Syndrome
Marta Kaminska, Franceen Browman, Daria A Trojan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 7, 2026
Cell free miRNAs are pharmacodynamic biomarkers for enhanced Dicer activity by Enoxacin in human patients with Amyotrophic lateral sclerosis
Iddo Magen, Hannah Marlene Kaneb, Maria Masnata, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 30, 2026
The World Federation of Neurology Specialty Group in ALS/MND: toward strategic partnership and new frontiers
Matthew C Kiernan, Angela Genge, Julian Grosskreutz, et al.
Drugs in R&D
|
June 20, 2022
Analysis of the US Safety Data for Edaravone (Radicava<sup>®</sup>) From the Third Year After Launch
Angela Genge, Benjamin Rix Brooks, Björn Oskarsson, et al.
Page
of 12